Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include Ozempic and also drugs to treat asthma, breast cancer and leukemia.
medicare part d
Posted inNPR
Medicare negotiations underway to lower prices for next batch of drugs
In the shadow of President Trump’s efforts to lower drug prices, the Medicare drug price negotiation process that began in the Biden administration continues.
Posted inNPR
Medicare negotiated drug prices for the first time. Here’s what it got
The White House is set to announce how much it was able to save on Medicare drug prices. It’s the first time the federal program has negotiated lower prices with the pharmaceutical industry.
Posted inNPR
Medicare negotiations for lower drug prices near the finish line
Medicare’s new authority to negotiate lower prescription drug prices represents a signature accomplishment of the Biden-Harris administration. Here’s what to know as the first set of talks wraps up.
